These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 17357004)

  • 1. Clinicopathological considerations on angiogenic potential in neuroblastoma Schwannian stroma - poor tumours.
    Izycka-Swieszewska E; Drozyńska E; Rzepko R; Dembowska B; Grajkowska W; Brozyna A; Perek D; Balcerska A; Jaśkiewicz K
    Folia Neuropathol; 2007; 45(1):1-8. PubMed ID: 17357004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prominent microvascular proliferation in clinically aggressive neuroblastoma.
    Peddinti R; Zeine R; Luca D; Seshadri R; Chlenski A; Cole K; Pawel B; Salwen HR; Maris JM; Cohn SL
    Clin Cancer Res; 2007 Jun; 13(12):3499-506. PubMed ID: 17575212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo angiogenic activity of neuroblastoma correlates with MYCN oncogene overexpression.
    Ribatti D; Raffaghello L; Pastorino F; Nico B; Brignole C; Vacca A; Ponzoni M
    Int J Cancer; 2002 Dec; 102(4):351-4. PubMed ID: 12402304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of microvascular density and the expression of vascular-endothelial growth factor (VEGF) and its membrane receptor Flk-1 in neuroblastoma].
    Drozyńska E; Izycka-Swieszewska E; Balcerska A; Bodalski J; Bohosiewicz J; Brozyna A; Bubała H; Chybicka A; Grajkowska W; Koltan S; Madziara W; Rybczyńska A; Słociak M; Sońta-Jakimczyk D; Stolarska M; Perek D; Wachowiak J; Wysocki M
    Med Wieku Rozwoj; 2006; 10(3 Pt 1):745-55. PubMed ID: 17317905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome analysis and gene expression profiling of neuroblastoma and ganglioneuroblastoma reveal differences between neuroblastic and Schwannian stromal cells.
    Coco S; Defferrari R; Scaruffi P; Cavazzana A; Di Cristofano C; Longo L; Mazzocco K; Perri P; Gambini C; Moretti S; Bonassi S; Tonini GP
    J Pathol; 2005 Nov; 207(3):346-57. PubMed ID: 16178058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of the International Neuroblastoma Pathology Classification in Neuroblastoma (Schwannian stroma-poor) and comparison with other prognostic factors: a study of 182 cases from the Spanish Neuroblastoma Registry.
    Burgues O; Navarro S; Noguera R; Pellín A; Ruiz A; Castel V; Llombart-Bosch A
    Virchows Arch; 2006 Oct; 449(4):410-20. PubMed ID: 16941154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enlarged and prominent nucleoli may be indicative of MYCN amplification: a study of neuroblastoma (Schwannian stroma-poor), undifferentiated/poorly differentiated subtype with high mitosis-karyorrhexis index.
    Kobayashi C; Monforte-Munoz HL; Gerbing RB; Stram DO; Matthay KK; Lukens JN; Seeger RC; Shimada H
    Cancer; 2005 Jan; 103(1):174-80. PubMed ID: 15549714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on MYCN gene amplification and CD44 expression in neuroblastoma].
    Hu HL; He LJ
    Zhonghua Bing Li Xue Za Zhi; 2004 Aug; 33(4):332-6. PubMed ID: 15363318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of cancer-associated fibroblasts inversely correlates with Schwannian stroma in neuroblastoma tumors.
    Zeine R; Salwen HR; Peddinti R; Tian Y; Guerrero L; Yang Q; Chlenski A; Cohn SL
    Mod Pathol; 2009 Jul; 22(7):950-8. PubMed ID: 19407854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral neuroblastic tumours in eastern Denmark 1972-2002.
    Zimling ZG; Rechnitzer C; Rasmussen M; Petersen BL
    APMIS; 2007 Jan; 115(1):66-74. PubMed ID: 17223852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological diagnosis for neuroblastoma using the combination of highly sensitive analysis of prognostic factors.
    Tajiri T; Tanaka S; Higashi M; Kinoshita Y; Takahashi Y; Tatsuta K; Suita S
    J Pediatr Surg; 2006 Mar; 41(3):560-6. PubMed ID: 16516635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PRAF2 stimulates cell proliferation and migration and predicts poor prognosis in neuroblastoma.
    Yco LP; Geerts D; Koster J; Bachmann AS
    Int J Oncol; 2013 Apr; 42(4):1408-16. PubMed ID: 23440329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesis.
    Chlenski A; Liu S; Crawford SE; Volpert OV; DeVries GH; Evangelista A; Yang Q; Salwen HR; Farrer R; Bray J; Cohn SL
    Cancer Res; 2002 Dec; 62(24):7357-63. PubMed ID: 12499280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor angiogenesis correlates with metastatic disease, N-myc amplification, and poor outcome in human neuroblastoma.
    Meitar D; Crawford SE; Rademaker AW; Cohn SL
    J Clin Oncol; 1996 Feb; 14(2):405-14. PubMed ID: 8636750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of inhibitor-of-apoptosis protein (IAP) livin by neuroblastoma cells: correlation with prognostic factors and outcome.
    Kim DK; Alvarado CS; Abramowsky CR; Gu L; Zhou M; Soe MM; Sullivan K; George B; Schemankewitz E; Findley HW
    Pediatr Dev Pathol; 2005; 8(6):621-9. PubMed ID: 16328668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The angiogenic growth factors HGF and VEGF in serum and plasma from neuroblastoma patients.
    Sköldenberg EG; Larsson A; Jakobson A; Hedborg F; Kogner P; Christofferson RH; Azarbayjani F
    Anticancer Res; 2009 Aug; 29(8):3311-9. PubMed ID: 19661350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of MYCN amplification and ploidy in favorable-stage neuroblastoma: a report from the Children's Oncology Group.
    Schneiderman J; London WB; Brodeur GM; Castleberry RP; Look AT; Cohn SL
    J Clin Oncol; 2008 Feb; 26(6):913-8. PubMed ID: 18281664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of modified Shimada classification with MYCN and 1p36 status detected by fluorescence in situ hybridization in neuroblastoma.
    Altungoz O; Aygun N; Tumer S; Ozer E; Olgun N; Sakizli M
    Cancer Genet Cytogenet; 2007 Jan; 172(2):113-9. PubMed ID: 17213019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor origin of endothelial cells in human neuroblastoma.
    Pezzolo A; Parodi F; Corrias MV; Cinti R; Gambini C; Pistoia V
    J Clin Oncol; 2007 Feb; 25(4):376-83. PubMed ID: 17264333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of CYP3A4/5 genotypes and expression with the survival of patients with neuroblastoma.
    Darwish MH; Farah RA; Farhat GN; Torbey PH; Ghandour FA; Bejjani-Doueihy NA; Dhaini HR
    Mol Med Rep; 2015 Feb; 11(2):1462-8. PubMed ID: 25370902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.